Skip to content
lifestyle.capitolhilltimes.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Matica Biotechnology, Inc.
Matica Bio and VaxDome Partner to Develop Antigen-Agnostic Antiviral-Vaccine Hybrids with Influenza as One of the Disease Models
July 6, 2026
Matica Biotechnology Launches Integrated Korea IIT Platform Solution to Accelerate Global Advanced Therapy Development
June 18, 2026
Matica Biotechnology and Cirsium Biosciences Announce Adoption of Matica Open Access Platform to Accelerate Flexible AAV Manufacturing
June 16, 2026
Matica Biotechnology announces engagement by University Health Network (UHN) to supply cGMP Manufacturing of IL-10 Adenoviral Therapy for Lung Transplantation
June 9, 2026